Suppr超能文献

欧洲心脏手术风险评估系统II与肝功能障碍

European System for Cardiac Operative Risk Evaluation II and Liver Dysfunction.

作者信息

Ludusanu Andreea, Tanevski Adelina, Ciuntu Bogdan Mihnea, Bobeica Razvan Lucian, Chiran Dragos Andrei, Stan Cristinel Ionel, Radu Viorel Dragos, Boiculese Vasile Lucian, Tinica Grigore

机构信息

Department of Morphofunctional Sciences I-Anatomy, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.

Department of General Surgery, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.

出版信息

Biomedicines. 2025 Jan 10;13(1):154. doi: 10.3390/biomedicines13010154.

Abstract

The importance of liver dysfunction in predicting mortality in patients undergoing cardiovascular surgery is an important topic due to the general desire to improve current risk scores such as EUROSCORE II (European System for Cardiac Operative Risk Evaluation), with EUROSCORE III being currently under development. The model for End-Stage Liver Disease (MELD) Score has already proven its utility in predicting outcomes for patients undergoing abdominal, cardiovascular or urological surgery. In the present study, we want to see its usefulness in proving the postoperative mortality in patients undergoing coronary artery bypass surgery. This was a retrospective study, and it included 185 patients, with 93 survivors being randomly chosen from a total of 589 surviving patients using age, emergency and the weight of cardiac procedures as criteria to match the 92 deceased patients during hospitalization in the postoperative period who underwent coronary artery bypass grafting (CABG) alone or CABG and other concomitant cardiovascular interventions during a 10-year period of time. We calculated for all these patients, at the time of admission, the MELD Score and EUROSCORE II, and we analyzed the predictive performance of the two scores and their constituents. In the multivariable model, patients with a MELD Score ≥ 5.54 had a 2.38-fold increased risk of death (95% C.I.: 1.43-3.96, = 0.001), while those with a EUROSCORE ≥ 10.37 had a 8.66-fold increased risk of death (95% C.I.: 3.09-24.29, < 0.001). After combining the two scores, the conditional scenario achieved a high overall accuracy of 84.32% ( < 0.001) in predicting mortality. Patients with a MELD Score ≥ 5.54, had good sensitivity and a very good specificity in terms of mortality prediction, but the conditional scenario, leveraging both risk scores, i.e., the MELD Score and EUROSCORE, offers the highest utility in terms of enhancing mortality prediction regarding these patients.

摘要

鉴于人们普遍希望改进当前的风险评分,如欧洲心脏手术风险评估系统II(EUROSCORE II),且欧洲心脏手术风险评估系统III目前正在开发中,肝功能障碍在预测心血管手术患者死亡率方面的重要性成为一个重要课题。终末期肝病模型(MELD)评分已在预测接受腹部、心血管或泌尿外科手术患者的预后方面证明了其效用。在本研究中,我们想看看它在证明冠状动脉搭桥手术患者术后死亡率方面的有用性。这是一项回顾性研究,纳入了185例患者,其中93例幸存者是从589例存活患者中随机选取的,选取标准为年龄、急诊情况以及心脏手术的权重,以匹配术后10年期间仅接受冠状动脉搭桥术(CABG)或接受CABG及其他同期心血管干预的92例住院期间死亡患者。我们在所有这些患者入院时计算了MELD评分和EUROSCORE II,并分析了这两个评分及其组成部分的预测性能。在多变量模型中,MELD评分≥5.54的患者死亡风险增加2.38倍(95%置信区间:1.43 - 3.96,P = 0.001),而EUROSCORE≥10.37的患者死亡风险增加8.66倍(95%置信区间:3.09 - 24.29,P < 0.001)。将两个评分结合后,条件模型在预测死亡率方面达到了84.32%的高总体准确率(P < 0.001)。MELD评分≥5.54的患者在死亡率预测方面具有良好的敏感性和非常好的特异性,但利用MELD评分和EUROSCORE这两个风险评分的条件模型在提高这些患者死亡率预测方面具有最高的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1543/11762396/6f10948d4448/biomedicines-13-00154-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验